[TNXP] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
12-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 6.31%
YoY- 4.06%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 9,027 0 0 0 0 0 0 -
PBT -23,140 -23,553 -14,179 -5,840 -6,087 -4,780 -9,806 15.37%
Tax -196 0 0 0 0 0 0 -
NP -27,395 -23,553 -14,179 -5,840 -6,087 -4,780 -9,806 18.66%
Tax Rate - - - - - - - -
Total Cost 36,422 23,553 14,179 5,840 6,087 4,780 9,806 24.43%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -254.17 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -244.55 -449.35 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -244.55 -449.35 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.